• 939 Citations
  • 17 Scopus h-Index
20052019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2005 2019

Filter
Letter
2018

Reframing the value of treatments for relapsed/refractory multiple myeloma

Ailawadhi, S., Panjabi, S., Campioni, M., Majer, I. & Jakubowiak, A., Jul 1 2018, In : Journal of Managed Care and Specialty Pharmacy. 24, 7, p. 711-712 2 p.

Research output: Contribution to journalLetter

Antineoplastic Combined Chemotherapy Protocols
Multiple Myeloma
Cost-Benefit Analysis
2015
1 Citation (Scopus)

Localized LECT2 amyloidosis of the adrenal gland with coexisting MGUS: a diagnostic challenge

Angell, T. E., Swaika, A., Sood, N., Goldfarb, M., Siddiqi, I. & Ailawadhi, S., Jun 7 2015, In : Annals of Hematology. 94, 9, p. 1603-1604 2 p.

Research output: Contribution to journalLetter

Adrenal Gland Diseases
Monoclonal Gammopathy of Undetermined Significance
Amyloidosis
Adrenal Glands
Intercellular Signaling Peptides and Proteins

Multiple asymptomatic colon plasmacytomas: a diagnostic and therapeutic dilemma

Swaika, A., Advani, P. P., Ghosh, R. N., Jha, A. K., Jiang, L. & Ailawadhi, S., Jun 1 2015, In : Annals of Hematology. 94, 6, p. 1061-1062 2 p.

Research output: Contribution to journalLetter

Asymptomatic Diseases
Plasmacytoma
Multiple Myeloma
Colonic Neoplasms
Colon
22 Citations (Scopus)

Phase i safety data of lenalidomide, bortezomib, dexamethasone, and elotuzumab as induction therapy for newly diagnosed symptomatic multiple myeloma: SWOG S1211

Usmani, S. Z., Sexton, R., Ailawadhi, S., Shah, J. J., Valent, J., Rosenzweig, M., Lipe, B., Zonder, J. A., Fredette, S., Durie, B., Hoering, A., Bartlett, B. & Orlowski, R. Z., Aug 7 2015, In : Blood Cancer Journal. 5, e334.

Research output: Contribution to journalLetter

Antineoplastic Combined Chemotherapy Protocols
Antibodies, Monoclonal, Humanized
Induction Chemotherapy
Thalidomide
Multiple Myeloma
1 Citation (Scopus)

Phase I safety data of lenalidomide, bortezomib, dexamethasone, and elotuzumab as induction therapy for newly diagnosed symptomatic multiple myeloma: SWOG S1211

Usmani, S. Z., Sexton, R., Ailawadhi, S., Shah, J. J., Valent, J., Rosenzweig, M., Lipe, B., Zonder, J. A., Fredette, S., Durie, B., Hoering, A., Bartlett, B. & Orlowski, R. Z., Aug 14 2015, In : Blood Cancer Journal. 5, 8, e334.

Research output: Contribution to journalLetter

Multiple Myeloma
Dexamethasone
Safety
Therapeutics
lenalidomide
2014
1 Citation (Scopus)

Disseminated histoplasmosis in a renal transplant patient

Swaika, A., Ailawadhi, S. & Menke, D. M., 2014, In : International Journal of Hematology. p. 315-316 2 p.

Research output: Contribution to journalLetter

Histoplasma
Histoplasmosis
Kidney Transplantation
Chronic Kidney Failure
Transplants
2008

Vascular endothelial growth factor polymorphisms in early-stage non-small-cell lung cancer

Patel, M., Ailawadhi, S., Hernandez-Ilizaliturri, F. & Wilding, G. E., 2008, In : Journal of Clinical Oncology. 26, 19, p. 3289-3290 2 p.

Research output: Contribution to journalLetter

Neoplasm Staging
Gene Frequency
Non-Small Cell Lung Carcinoma
Vascular Endothelial Growth Factor A
Lung Neoplasms
2007

HLA-identical sibling stem-cell transplantation in first-remission AML

Ailawadhi, S. & Padmanabhan, S., Dec 15 2007, In : Blood. 110, 13, p. 4619 1 p.

Research output: Contribution to journalLetter

Remission Induction
Histocompatibility
Hematopoietic Stem Cell Transplantation
Stem Cell Transplantation
Acute Myeloid Leukemia